ES2068154A1 - Nuevas formulaciones analgesicas con amplio intervalo de accion. - Google Patents

Nuevas formulaciones analgesicas con amplio intervalo de accion.

Info

Publication number
ES2068154A1
ES2068154A1 ES09301571A ES9301571A ES2068154A1 ES 2068154 A1 ES2068154 A1 ES 2068154A1 ES 09301571 A ES09301571 A ES 09301571A ES 9301571 A ES9301571 A ES 9301571A ES 2068154 A1 ES2068154 A1 ES 2068154A1
Authority
ES
Spain
Prior art keywords
formulations
new
action
broad spectrum
analgesic formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09301571A
Other languages
English (en)
Other versions
ES2068154B1 (es
Inventor
Molina Ramon Gallo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Industrial Farmaceutica Cantabria SA
Original Assignee
Industrial Farmaceutica Cantabria SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Industrial Farmaceutica Cantabria SA filed Critical Industrial Farmaceutica Cantabria SA
Priority to ES9301571A priority Critical patent/ES2068154B1/es
Publication of ES2068154A1 publication Critical patent/ES2068154A1/es
Application granted granted Critical
Publication of ES2068154B1 publication Critical patent/ES2068154B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

NUEVAS FORMULACIONES ANALGESICAS CON AMPLIO INTERVALO DE ACCION. SE DESCRIBEN NUEVAS FORMULACIONES ANALGESICAS LIQUIDAS PARA USO ORAL, ADECUADAS PARA EL TRATAMIENTO SISTEMICO DEL DOLOR. DICHAS FORMULACIONES CONTIENEN UN AGONISTA OPIOIDE JUNTO A UN SOPORTE INERTE QUE ACTUA CONTROLANDO LA LIBERACION DEL PRINCIPIO ACTIVO EN EL TIEMPO. ESTAS NUEVAS FORMULACIONES CONTIENEN LAS SIGUIENTES CANTIDADES DE INGREDIENTES POR 100 ML. DE VOLUMEN TOTAL: CLORHIDRATO DE MORFINA TOTAL: 1,5-3G; FITOCOLOIDE ESTANDARIZADO: 1,25-1,75 G. ESTAS FORMULACIONES TIENEN APLICACION EN LA INDUSTRIA FARMACEUTICA.
ES9301571A 1993-07-13 1993-07-13 Nuevas formulaciones analgesicas con amplio intervalo de accion. Expired - Fee Related ES2068154B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9301571A ES2068154B1 (es) 1993-07-13 1993-07-13 Nuevas formulaciones analgesicas con amplio intervalo de accion.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9301571A ES2068154B1 (es) 1993-07-13 1993-07-13 Nuevas formulaciones analgesicas con amplio intervalo de accion.

Publications (2)

Publication Number Publication Date
ES2068154A1 true ES2068154A1 (es) 1995-04-01
ES2068154B1 ES2068154B1 (es) 1995-11-16

Family

ID=8282538

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9301571A Expired - Fee Related ES2068154B1 (es) 1993-07-13 1993-07-13 Nuevas formulaciones analgesicas con amplio intervalo de accion.

Country Status (1)

Country Link
ES (1) ES2068154B1 (es)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024073A (en) * 1972-01-08 1977-05-17 Toray Industries, Inc. Hydrogel and production thereof
EP0171742A2 (en) * 1984-08-10 1986-02-19 E.I. Du Pont De Nemours And Company Transdermal delivery of opioids
ES8608890A1 (es) * 1985-09-16 1986-09-01 Carulla Vekar S A Preparado farmaceutico liquido a base de teofilina de efec- tos retardados y procedimiento para su obtencion
EP0300806A1 (en) * 1987-07-24 1989-01-25 Vestar, Inc. Opioid analgesic liposomal delivery-release system
WO1992000732A1 (en) * 1990-07-04 1992-01-23 Kabi Pharmacia Ab Therapeutical composition and process for its preparation

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024073A (en) * 1972-01-08 1977-05-17 Toray Industries, Inc. Hydrogel and production thereof
EP0171742A2 (en) * 1984-08-10 1986-02-19 E.I. Du Pont De Nemours And Company Transdermal delivery of opioids
ES8608890A1 (es) * 1985-09-16 1986-09-01 Carulla Vekar S A Preparado farmaceutico liquido a base de teofilina de efec- tos retardados y procedimiento para su obtencion
EP0300806A1 (en) * 1987-07-24 1989-01-25 Vestar, Inc. Opioid analgesic liposomal delivery-release system
WO1992000732A1 (en) * 1990-07-04 1992-01-23 Kabi Pharmacia Ab Therapeutical composition and process for its preparation

Also Published As

Publication number Publication date
ES2068154B1 (es) 1995-11-16

Similar Documents

Publication Publication Date Title
ES2088312T3 (es) Formulacion de liberacion controlada que contiene tramadol.
ZA955547B (en) Multiple unit pharmaceutical preparation
ATE131039T1 (de) Arzneimittel in gelform in einem spender.
ES2117015T3 (es) Composiciones que contienen sumatriptan.
BR0108584A (pt) Formulações contendo um fármaco anticolinérgico para o tratamento da broncopneumopatia crÈnica obtrutiva
ITRM930591A0 (it) Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
DK0407028T3 (da) Anordning til inhalation af medikamenter og sammensætning af medikamenter
ES2039480T3 (es) Una forma de dosificacion liquida para administracion oral de una sustancia farmaceuticamente activa.
DK196189D0 (da) Oralt osmotisk dispenseringssystem indeholdende et farmakologisk aktivt stof
HU900108D0 (en) Composition of controlled active ingredient delivery, operating by hydrogel
AR240250A1 (es) Procedimiento para la preparacion de una nueva formualcion farmaceutica oral que contiene omeprazol como ingrediente activo.
FI932553A7 (fi) Uusia farmaseuttisia formulaatioita, jotka sisältävät farmakologisesti aktiivista ionisoitavaa ainetta, sekä menetelmä niiden valmistamiseksi
MX9205384A (es) Dispositivo de administracion transdermica de un agente activo para uso veterinario.
IL101358A0 (en) Crystalline tiagabine hydrochloride monohydrate,its preparation and pharmaceutical compositions containing it
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
IL139318A0 (en) Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same
ATE353224T1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
ES2068154A1 (es) Nuevas formulaciones analgesicas con amplio intervalo de accion.
DK0521353T3 (da) Lægemiddel med antineoplastisk virkning, der som virksomt stof indeholder octadecyl-(2-(N-metylpiperidino)-ethyl)-phosphat og fremgangsmåde til fremstilling deraf
ATE234096T1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
BR9912260A (pt) Emplastro contendo um sistema terapêutico transdérmico e dose única para ministração
ES2146683T3 (es) Uso de bifemelano para la fabricacion de un medicamento para el tratamiento de trastornos hipercineticos.
IT1254707B (it) Uso topico della calcitonima per la preparazione di medicamenti nella cataratta idiopatica senile e una composizione farmaceutica che la contiene
ES2116452T3 (es) Composiciones farmaceuticas que comprenden agonistas de receptores 5ht1 y potenciadores de la absorcion.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040601